Clinical management of women at increased risk for breast cancer
Clinical management of women at increased risk for breast cancer
复制标题
乳腺癌风险增加女性的临床管理
DOI：
10.1007/bf00666431
复制
发表时间：
2004
影响因子：
3.8
通讯作者：
E. Higginbotham
中科院分区：
文献类型：
--
作者：
V. Vogel;A. Yeomans;E. Higginbotham
SummaryA large number of women in the population are at risk for the development of breast cancer. Methods now exist to accurately assess risk and to provide quantitative estimates of the chance of a woman developing breast cancer in her lifetime. Histologic assessment of premalignant breast pathology aids in the evaluation of risk. The availability of primary chemoprevention clinical trials reduces the number of indications for prophylactic mastectomy. Women at risk for breast cancer and women who have had a malignant lesion at another anatomic site have an increased risk for new cancers at multiple sites. We propose screening strategies based on epidemiologic information about the risks of these diseases and on the predictive value of the available screening tests. The merits and inadequacies of specific management strategies are considered. We review the risks and benefits of estrogen replacement therapy for women at increased risk for breast cancer and consider the ethical implications of both risk assessment and the various interventions.
登录
查看更多内容
影响因子：
11.2
作者：
B. Henderson;R. Ross;L. Bernstein
通讯作者：
B. Henderson;R. Ross;L. Bernstein
DOI：
10.1001/jama.1992.03490150089030
发表时间：
1992-10
期刊：
JAMA
影响因子：
--
作者：
W. Willett;D. Hunter;M. Stampfer;G. Colditz;J. Manson;D. Spiegelman;B. Rosner;C. Hennekens;F. Speizer
通讯作者：
W. Willett;D. Hunter;M. Stampfer;G. Colditz;J. Manson;D. Spiegelman;B. Rosner;C. Hennekens;F. Speizer
影响因子：
158.5
作者：
LOVE, RR;MAZESS, RB;DEMETS, DL
通讯作者：
DEMETS, DL
影响因子：
5
作者：
A. Saftlas;J. Wolfe;R. Hoover;L. Brinton;C. Schairer;M. Salane;M. Szklo
通讯作者：
A. Saftlas;J. Wolfe;R. Hoover;L. Brinton;C. Schairer;M. Salane;M. Szklo
影响因子：
56.9
作者：
HOLLSTEIN, M;SIDRANSKY, D;HARRIS, CC
通讯作者：
HARRIS, CC